- Raised Undisclosed Round, Jan 2017
About
Coronis Neurosciences is a specialty pharmaceutical company focused on the development of therapies for neurocognitive and neurodegenerative disorders. Coronis owns a pipeline of several clinical- and preclinical-stage molecules and strives to build value through the clinical development of proprietary formulated drugs. The company's pipeline includes CP201, its leading drug, developed to treat ADNP syndrome. CP201 is a trans-nasally delivered peptide (NAP) developed for the treatment of ADNP syndrome in children. ADNP syndrome, an autism spectrum disorder, is a rare neurogenetic disease caused by de novo mutations in the ADNP gene. Coronis also develops CP101, a drug to treat cognitive impairment associated with schizophrenia (CIAS) using a proprietary new small peptide.
Funding history · 1 round · — total
Headcount over time
Q&A
- What is the current status of Coronis Neurosciences?
- Coronis Neurosciences is currently inactive, having ceased operations in May 2022.
- When was Coronis Neurosciences founded?
- Coronis Neurosciences was founded in January 2014.
- What is Coronis Neurosciences' primary focus?
- Coronis Neurosciences is a specialty pharmaceutical company focused on developing therapies for neurocognitive and neurodegenerative disorders.
- What is Coronis Neurosciences' lead drug candidate?
- Coronis Neurosciences' lead drug candidate is CP201, developed to treat ADNP syndrome, a rare neurogenetic disease.
- What other drug is Coronis Neurosciences developing?
- Coronis Neurosciences is also developing CP101, a drug aimed at treating cognitive impairment associated with schizophrenia (CIAS).
- How many employees does Coronis Neurosciences have?
- Coronis Neurosciences has 1-10 employees.
- When was Coronis Neurosciences' last known funding round?
- Coronis Neurosciences had a funding round in January 2017, with ADNP-KRF as an investor.
- Who are the key executives at Coronis Neurosciences?
- Eric J. Messika is the President & CEO, and Illana Gozes is the CSO of Coronis Neurosciences.
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/12902749 |
Identifiers & details
| Founded | 2014-1 |
|---|---|
| Employees (exact) | 2 |
| Status reason | Non Active, May 2022 ceased to operate |